CP-197 Protocol compliance in the treatment of hypercholesterolaemia with protein convertase SUBTILISIN-LIKE/KEXIN type 9 inhibitors (PCSK9 inhibitors)
CP-197 Protocol compliance in the treatment of hypercholesterolaemia with protein convertase SUBTILISIN-LIKE/KEXIN type 9 inhibitors (PCSK9 inhibitors)